Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Download PDF release →Ad hoc announcement pursuant to Art. 53 LR
Liestal, Switzerland, 24 March 2026: Curatis Holding AG (SIX:CURN) reports business revenues of CHF 10.8m in fiscal year 2025. A major milestone was achieved in the development of our lead project, corticorelin.
Curatis Holding AG · Weierweg 7, CH-4410 Liestal · SIX: CURN